Related by context. All words. (Click for frequent words.) 74 Document de Référence 67 No. D.# 65 Reference Document 64 document de référence 61 Financiers Filed 61 French Autorite des 60 French Autorité des Marchés 59 Prospectus dated 58 Risque section 58 Form #Q filed 57 AMF website http:/www.amf-france.org 57 R.# [001] 57 Filing Statement dated 57 ASX Announcement 56 DURECT Form 56 Reproduced Record RR 56 Company Prospectus dated 56 Legal #.# 55 Risk Factors Facteurs de 55 Sonus Quarterly Report 55 suppl 55 Prospectus Supplement filed 54 Br J Psychiatry 54 rapport de gestion 54 AMF website www.amf 54 note d' opération 54 Income Tax Regs 53 Packeteer Form 53 CFR #.#b 53 Id. § 53 Section 3.D 53 2 Chifley Square 53 ITEM 1A 53 Proxy Statement dated 53 Appendix 3B Page 53 onForm 53 DURECT Quarterly Report 53 Prospectus Supplement dated 53 Defined Terms 52 Supplement dated 52 CORPORATE DIRECTORY 52 • jomalley@rgj.com • 52 #.# subd [004] 52 Suppl 52 USC § § #e 52 prospectus supplement dated 52 Schizophr Res 52 ADDITIONAL INFORMATION .vectorless 52 Repl. 52 § #-#-# b [003] 52 See ARS § 52 Administrative Proceeding File 52 accompanying prospectus dated 51 Information Circular dated 51 J Nerv Ment Dis 51 Note en Réponse 51 • dhogan@news-press.com • 51 Restated Promissory Note 51 Nephrol Dial Transplant 51 STATEMENT ON SCHEDULE 51 Ord. 51 Facsimile +# 0 51 By DOROTHY SCHNEIDER 51 ps :# 51 3d Ex 51 BANJO 51 CUSIP ISIN 51 Suppl. 51 J Affect Disord 51 By Kari Petrie 51 #g# 2 51 des bons Le 51 SR ISE 51 Original Bidder Statement 51 neu ar 51 By fitsnews • 51 File Nos. #-# 51 S1 S# [002] 51 Schizophr Bull 51 • kdonica@thetowntalk.com • 51 CFR § #.#b 51 EXPLANATORY MEMORANDUM 51 Pricing Supplement 50 Nuvelo filings 50 GENERAL INFORMATION 50 See id 50 T8N 50 Garrcon Technical Report 50 Biol Psychiatry 50 PURSUANT TO RULE 50 Bulk Ex Kandla 50 Ce texte est également 50 See USSG § #B#.# 50 NDTV HINDU NIGHT VISION 50 NIH Publication 50 • tbrouk@jconline.com • 50 #S #S [002] 50 I# I# [002] 50 J Clin Psychiatry 50 By GUNNAR OLSON 50 :# [002] 50 Pub. 50 § #E 50 WpHG mit dem Ziel 50 suppl. 50 J Thorac Cardiovasc Surg 50 EDGAR Online via COMTEX 50 Phys Ther 50 Voicemail Line 50 Regulation RRO 50 BY LUIS HERNANDEZ 50 Projet de 50 SEDAR www.sedar.com www.sedar.com 50 caption Item 1A 50 TABLE OF CONTENTS 50 Appendix 4E 50 U4 OR Book 50 #S #S [003] 50 THE CANADIAN SECURITIES AUTHORITIES 50 By ČTK Published 50 RICK HARTFORD 50 Note en Reponse 50 Form NT #Q 50 #d# [001] 50 By SOPHIA VORAVONG 50 FOF ¶ 49 END FOOTNOTE FOOTNOTE 49 y ddamwain 49 Supplemental Circular 49 USC § #a [002] 49 -# Fed. Cir 49 Offer Document dated 49 By VEXNEWS ⋅ 49 USC § #u 49 Certifications Commercial Items 49 MBELL@DNJ.COM 49 theSecurities 49 Psychol Med 49 Arch Gen Psychiatry 49 heading ITEM 1A 49 • svoravong@jconline.com • 49 #.#-# b [001] 49 RISKS AND UNCERTAINTIES 49 § 7B 49 Default Announcement 49 NJSA 2C :2 49 Statement dated 49 Variable Interest Entities FIN 49 :7 49 Taleo Quarterly Report 49 Financiers Registered 49 DISCLOSURE NOTICE 49 #a #a [001] 49 Form# Q 49 NicOx SA website http:/www.nicox.com 49 WOMEN 'S SEEDED LOSERS 49 par voie de 49 T# R# 49 Offering Memorandum dated 49 III • dhusty@news-press.com 49 NJSA 2C :5 49 ir@crucell.com www.crucell.com 49 Ebix periodic filings 49 Document de référence 49 Corporate Governance Statement 49 Euronext Paris Code Isin 49 2DAVIDP 49 -Epidemiol 49 Eur J Pharmacol 49 Child Adolesc Psychiatry 49 france.org 49 NJSA #A 49 #.#-# [005] 49 • crunnells@news-press.com • 49 Psychiatry Res 49 Int Clin Psychopharmacol 49 Accounting Guideline 49 #.#.# #.#.# [010] 49 Skimask 49 Marches Financiers Registered 48 Form 8K filed 48 #-#-# [053] 48 See INA § 48 = gat. getTracker UA 48 Docket Entry No. 48 Id. ¶ 48 AND RISK FACTORS 48 Psychopharmacol Bull 48 J Psychiatr Res 48 headings Forward Looking 48 C# [002] 48 • cslyder@jconline.com • 48 patrick.graham @ thomson.com 48 Ambrilia proceedings 48 Red Hat alert RHSA 48 Marches Financiers 48 :5 48 BY TREVOR HUGHES 48 S7 S# 48 PolyMedix filings 48 without limitation Nuvelo 48 abstr 48 • MBELL@DNJ.COM • 48 PCAOB Auditing Standard 48 AnnualReport 48 société anonyme 48 Orthop Surg 48 de noviembre de 48 Marston RBL 48 TCA § #-#-# [003] 48 • kpetrie@stcloudtimes.com • 48 #.# subd [003] 48 Facsimile +# 8 48 xiv inclusive 48 2DAVIDP http:/www.midweekpolitics.com http:/www.RYAN DAVIS 48 CFR § #.# [004] 48 de la société daté 48 See Annexure 48 Schedule #A 48 Ann Oncol 48 caption Cautionary Statement 48 END FOOTNOTE * 48 adrian.krajewski @ thomson.com 48 #a# [003] 48 AQUARIUS PLATINUM LIMITED 48 try var pageTracker 48 CICA Accounting Guideline 48 Hum Mol Genet 48 Rackspace Hosting Form 48 #.#-# b [002] 48 #.# 5T 48 Scheme Booklet 48 Replacement Bidder Statement 48 Docket Number 48 2DR 48 USC § #a c 48 BY MARCY MIRANDA 48 Kenilworth Wardens Jnrs 48 marches financiers 48 headings Risk Factors 48 AIF dated 48 Int J Geriatr Psychiatry 48 PLEASE TELEPHONE + 48 BY PAUL SRUBAS 48 #/#/# Appendix 3B [003] 48 TVID 48 daté du 48 TORONTO CANADA Marketwire 48 • tzulewski@thespectrum.com • 48 Bipolar Disord 48 By FameNews 48 Participant Passcode 48 DP Opinion 48 IMPORTANT DATES 48 BY LAURA RUANE 48 Colo. Sess 48 UPI NewsTrack Business 48 @ stolt.com 47 CONTENTS Page 47 Old Woodstock Tn 47 nepalnews.com pb 47 Unlisted Options 47 #-#-# [058] 47 Explanatory Note 47 Escrowed Shares 47 MB Docket 47 .W. McNichols 47 CNP Assurances filings 47 Circular dated 47 USC § #a [001] 47 Worthing Utd Yth 47 0Â 47 #R [004] 47 Am J Epidemiol 47 By RIA MEGNIN 47 Autorité des Marchés Financiers 47 LSE Trading Symbol 47 WL # SDNY [001] 47 Item 1a 47 www.aetna.com/#annualreport 47 # Fax +# [004] 47 Kusum Pugalia 47 Résultats 47 SFinley San Francisco 47 eff. 47 PG HBO2 47 Prog Neuropsychopharmacol Biol Psychiatry 47 Regarding Forward Looking Statements 47 By Terri Rupar 47 • HallieWoods@coloradoan.com • 47 R HBO2 47 Pa.CSA § 47 By Janet Hefler 47 TMR Newswire 47 Bigotry Monitor Volume 47 #.#.i#.rpm 47 See TCA § 47 #-#-# COPYRIGHT 47 Int J Epidemiol 47 Legislative Decree 47 pjg 47 USC § #c 47 C.# 47 http:/www.amf-france.org 47 • randypeterson@dmreg.com • 47 SDNY Mar. 47 Orchestral Performance Mahler Symphony 47 marie gabrielle.cajoly @ addaxpetroleum.com 47 #-# [027] 47 Prospectus Supplement 47 +#- 0 #-# [001] 47 By Mark Shail 47 Clin Infect Dis 47 MANAGEMENT DISCUSSION AND ANALYSIS 47 LewisM 47 Courierarea Sports Shorts 47 By DENES HUSTY 47 By Zachary Braziller 47 #/#/EC [002] 47 By Paul Srubas 47 By Anette Jönsson 47 T#N 47 II Item 1A 47 Risks Regarding Forward 47 ticker symbol CA4 47 #/#/# Appendix 3Y Page 47 ord = 47 Ivernia SEDAR profile 47 USC #d 47 ESMO Accepted Abstract 47 HKEY CLASSES ROOT CLSID 47 Prof. Code § 47 USC #a [001] 47 By Tink Holloway 47 -Genereaux 47 Fam. Code § 47 -Cedomir Jovanovic 47 & gt 47 Ann Rheum Dis 47 Form #KSB filed 47 • SeanDuff@coloradoan.com • 47 B# [004] 47 SEDAR www.SEDAR.com 47 See USSG 47 5TH CIR 47 symbol SPPN 47 Mob +# 0 47 NDTV HINDU # 47 Opp'n 47 § #-#-# g 47 Mindax Limited 47 SPECIAL BUSINESS 47 Half Yearly Report 47 J Clin Psychopharmacol 47 #p. 47 Kidney Int 47 SPECIAL WRITER • 47 BY NATE TAYLOR 47 REMUNERATION REPORT Audited 47 FR Doc 47 Management Proxy Circular 47 PFIZER DISCLOSURE NOTICE 47 USC § #t 47 Penwest Quarterly Report 47 warrant indenture dated 47 @ gov.mt 47 J Rheumatol 47 Appointment expires 47 #b c 47 disponible en français 46 EDUCATION WRITER • 46 Ann Neurol 46 Attunity Annual Report 46 7r 46 Offerors Commercial Items 46 S# S# [001] 46 Acta Psychiatr Scand 46 Adresse 46 i#.rpm 46 Complaint ¶ 46 Private Securities LitigationReform Act 46 Marifil Website Http :/ 46 Consequential Amendments 46 nach § 46 caption Item 46 Schedule #A filed 46 Final Prospectus 46 #a# [001] 46 See Restatement Second 46 • KellyLyell@coloradoan.com • 46 #a #a [003] 46 # Köln 46 NASD Marketplace Rule 46 Shelf Registration Statement 46 MSc Qualified Person 46 Form# K 46 STUDIO BRIEFING TV 46 Ce communiqué est aussi 46 Looking Statements -Dunshaughlin Co Meath 46 ZENIT.org 46 Engelhardtsen UK 46 FCC Rcd # 46 EMBO J. 46 #a #a [002] 46 prospectus dated 46 Directors Circular dated 46 RESTAURANT CRITIC • 46 Safe Harbor Regarding Forward 46 NT #Q 46 J Am Podiatr 46 + Despatch 46 financiers AMF 46 • TrevorHughes@coloradoan.com • 46 Nominal Dollars 46 periodic fillings 46 Listing Rule #.#.# [005] 46 website www.orvana.com 46 ASCO Accepted Abstract 46 Solagran Limited 46 Vion Annual Report 46 • SBRODEN@DNJ.COM • 46 Doc. No. 46 CEQA Guidelines 46 Steve Tomassetti 46 Jalan Tarian 46 ENGlobal filings 46 a'r yn 46 • PatFerrier@coloradoan.com • 46 ddydd Sadwrn 46 ar o 46 #.# subdivision [004] 46 Bidder Statement dated 46 § #-#.# [001] 46 ev enthusiast # 46 I. Item 1A 46 NYCRR #.# [003] 46 Supplementary Prospectus 46 entitled Cautionary Statement 46 Nucleic Acids Res 46 Taylor Hatmaker 46 RNS Number 46 Daniel Zugna 46 captions Item 1A 46 Rule #f 46 MAJOR INTERESTS IN SHARES 46 By Jessica Stanic 46 Telephone +# [001] 46 BALO 46 O. Reg 46 See Segmented Analysis 46 SECURITIES LITIGATION 46 :2 46 • gwatkins@thecalifornian.com • 46 Dar Danielson 46 Structured Finance Transactions 46 @ jackson.gannett.com • 46 cpmaz 46 Eur Respir J. 46 Preliminary Proxy Statement 46 op. 46 du Groupe 46 Funeral Notices 46 By Sameera Anand 46 #a [003] 46 Ann Intern Med 46 S1 S# [001] 46 EPA HQ OAR 46 • svijayan@thecalifornian.com • 46 Offering Circular dated 46 CVM Instruction 46 J Abnorm Psychol 46 Easington Spts 46 website www.thresholdpharm.com 46 www.amf france.org 46 .cagy veteran 46 len = 46 Civ. 46 By Andrea Petrou 46 § § #-# [001] 46 en réponse 46 :4 46 See OCGA § 46 Subiaco WA 46 Rachelle Morrow + 46 Leisure Vox Populi 46 CrisisWatch N ° 46 SecuritiesExchange Act 46 Neurobiol Aging 46 Les résultats 46 BJ# 46 # München 46 Eur Respir J 46 W3M 46 App. Div 46 Note Concerning Forward 46 Threshold Quarterly Report 46 #-# #-# [013] 46 By Adam Nutburn 46 § § #-# [003] 46 By JANET KLOCKENGA 46 SANTOS • pdelossant@thespectrum.com 45 PROPRIETARY LIMITED 45 Coleshill Utd 45 Pa.CS § 45 J Natl Cancer Inst 45 Risk Factors 45 Psychiatr Serv 45 DJ AIGCI Handbook 45 Sh hd 45 filedwith 45 Betty Verdun published 45 § #-#-# [004] 45 J Clin Oncol 45 Supplementary Explanatory Memorandum 45 Comision Nacional del 45 J Psychosom Res 45 #-#-# [046] 45 NJAC 6A 45 TD # PBTD 45 • skerbs@thespectrum.com • 45 web page www.diademresources.com 45 Transcept periodic 45 Quay Bristol BS1 45 HTA periodic 45 Va. Code § 45 mso ansi language 45 d SPLC 45 Supp. 45 Summary Table 45 http:/www.marinabio.com 45 Company Periodic Filings 45 RPA NI #-# 45 Cautionary Information 45 Pa.RAP 45 Chapter 6D 45 MoneyTV Week 45 Recent Accounting Pronouncements 45 Robert Brodsky rbrodsky@govexec.com 45 X#online.com exclusive 45 Suppl S# [002] 45 Berinsfield CC 45 SD Tex. 45 Item 1A Risk Factors 45 Nat Clin Pract 45 • whodkiew@greenbaypressgazette.com • 45 CFR § #.# [003] 45 Eur J Cancer 45 Adresa BURSA central 45 See BioWorld Today 45 D Staff WriterWednesday 45 P# [004] 45 suppl S# S# 45 financialstatements 45 AUTO CRITIC • 45 Trimeris Form 45 Vion Form 45 • bliberatore@news-press.com • 45 Cricklade Tn 45 Securities andExchange Commission 45 Explanatory Notes 45 Aliquam 45 Phil Lythell 45 ITEPA 45 By ICTWorld 45 caption Cautionary 45 Phil Rockstroh self 45 Torts § 45 • ribrown@dmreg.com • 45 See USSG § #A#.# 45 www.uqm.com 45 www.arisetech.com 45 MYoung Texas 45 Golcar Lib B 45 CFR § § #.# [002] 45 GAAP Adj 45 www.shell.com investor 45 Cochrane Database Syst Rev. 45 #b #S 45 By COVERS.com STAFF 45 Origin Appendix 45 #-#-# [013] 45 #N Range [001] 45 BY DAVID CASTELLON 45 Financiers AMF 45 Exercising jurisdiction 45 CD# [004] 45 Eur Heart 45 FERC Stats 45 Statements Cautionary Statements 45 - -loess soil 45 Certifications Commercial 45 Oli Skehan 45 FASB Statement 45 adopted FASB Interpretation 45 annexure mark 45 • ssoffian@news-press.com • 45 AFEP MEDEF recommendations 45 XML UDDI Universal 45 No. CA# 45 Repl 45 Marchés Financiers 45 RISK FACTORS 45 Med Assoc 45 Dot VN filings 45 Clinical Trials Update 45 fs# 45 ASX Announcements 45 Grn 45 Taleo Annual Report 45 FAR #.#-# Instructions 45 website www.amf france.org 45 Emisphere Quarterly Report 45 Subpart III 45 Telefax 45 • talex@dmreg.com • 45 Mainichi Shimbun Japan 45 Henley Tn 45 Autorité des marchés financiers 45 Vernon Supp 45 CFR #.# [005] 45 Real Windows Mp3 45 DRIVING COLUMNIST • 45 Longitudinal Section 45 Largo website www.largoresources.com 45 APWednesday September 45 Drill Hole Location 45 Bulletin des Annonces 45 § #.#.# [001] 45 Verena filings 45 @ snclavalin.com 45 Closing Wrap Up 45 WL # SDNY [002] 45 LEXIS # SDNY 45 annexed hereto 45 pgs #k 45 BROSSARD QUEBEC Marketwire 45 #M# Tel 45 Form #QSB 45 Mol Psychiatry 45 J Infect Dis 45 @ tbwa corporate.com 45 CFR § § #.# [001] 45 Evid. Code § § 45 #-#-# [011] 45 e# periodic 45 Advance Nanotech Annual Report 45 www.norsat.com 45 #:# abstract 45 Compr Psychiatry 45 § #.# [002] 45 Buckeye Newsstand 45 FINANCIAL RISK MANAGEMENT 45 USCA § 45 USC § #e 45 • ECCENTRIC STAFF WRITER 45 #.# subd [006] 45 Docket # 45 Replay Passcode 45 Section #.# [001] 45 Tuschl II '# patent 45 Sunesis Quarterly Report 45 P. #a 45 deb Size/MD5 # Size/MD5 [002] 45 II.#.# 45 heading RISK FACTORS 45 #-#.# [017] 45 Statutory Instrument 45 Dearbhla Walsh PBS 45 ticker ESEA 44 SEQ ID 44 • jprendergast@enquirer.com • 44 quoting Restatement Second 44 www.polymetmining.com 44 Obligatoires 44 Hanney Utd 44 THE AMENDED SCHEDULE 44 Oxford Blackbirds 44 caption Risk 44 Non Renounceable Rights 44 #-#-# [026] 44 App'x 44 ManTech Annual Report 44 Rule #h 44 http:/www.mpegla.com 44 4 # Unterschleissheim 44 Preliminary Prospectus 44 By Denes Husty 44 By RASHA AL 44 - Quarter EndedFrankfort Ilion 44 By Laura Baverman 44 Somerville Hse 44 james.peavy @ ambest.com 44 Narrative Description 44 -irrelevancies 44 Supplemental Schedule 44 Forward Looking Information 44 Abingdon Tn 44 Looking Statements 44 Legislation Reform Act 44 Legislative Decree No. 44 évaluation 44 QST page 44 Tronox Annual Report 44 doi #.#/S#-# 44 -Ganga aarti 44 marches financiers AMF 44 DOI #.#/S#-# 44 MRS § 44 Download PDF 44 -Richard Gitlen 44 por Gabriela Frias 44 By COLBY FRAZIER 44 Interpretive Guidance 44 • bbrunsman@enquirer.com • 44 'S MOST RECENT 44 cid = 44 Listing Application 44 DC Code § 44 Appendix 5B 44 Psychiatry Clin Neurosci 44 WELLS FINANCIAL CORP. 44 IV.#.# 44 Docket Entry 44 InfoSonics Annual Report 44 Cell Mol Biol 44 Centre culturel de 44 x hfrs 44 B Raja Rajkrishna 44 Definitive Proxy Statement 44 0E 44 Anadys Form 44 symbol VRNT 44 section #AA 44 Form 8K 44 symbol HBP 44 By Jenn Rowell 44 :6 44 By Joyanta Acharjee 44 unaudited consolidated balance sheets 44 CLIENT SERVING CAPACITY Rule 44 Contents Introduction 44 Sonus Annual Report 44 FAR #.#-# [001] 44 London E# 5HS 44 Hedging Relationships 44 USC § #b [002] 44 Claudio Abbado conductor 44 Private SecuritiesLitigation Reform Act 44 #/#/# Appendix 3B [001] 44 COA Circular 44 website www.enterraenergy.com 44 Actof 44 Georgia Nicols horoscopes 44 ABN AMRO Warrants 44 footnotes thereto 44 Didcot Cas 44 :9 44 Topics Covered Executive 44 Openwave Systems Quarterly Report 44 • DOUGDAVIS@DNJ.COM • 44 Subsections 44 Risk Factors Item 44 v Breadalbane 44 Consent Revocation Statement 44 #e Claud Estes 44 Announcements Platform 44 § #-#-# b [001] 44 § #-#-# [005] 44 • ckranz@enquirer.com • 44 SPDS dated 44 dpa db 44 CFR § #.# [001] 44 Remuneration Code 44 ticker symbol OPERA 44 BY JAMES PROFFITT 44 Subsequent Events 44 coded UPC # 44 Confidential Offering Memorandum 44 RIP Reel 44 discloseable transaction 44 VioQuest Annual Report 44 InterRent publicly 44 J Child Adolesc 44 FAR #.#-# Offeror Representations 44 #S #S [001] 44 GlobalOptions Group filings 44 Annual Report onForm 44 Del. Ch 44 • dzaleski@muncie.gannett.com • 44 U/G- deg deg 44 By Aidan Cuffe 44 6e 44 pour le premier trimestre 44 JP Lonergan 44 plc FRN Variable 44 MERCER INTERNATIONAL INC. RESTRICTED 44 Investment Considerations 44 Amendment Regulations 44 Jessica Machetta 44 FINANCIAL INFORMATION Item 44 #.#-# Offeror Representations 44 ¾ l 44 [013] 44 M spud #-#-# 44 Cautionary Note Concerning Forward 44 Certain Factors Affecting 44 Notice Regarding 44 Reconciliation Tables 44 CFR #.# [008] 44 #-# [034] 44 #.#.# [035] 44 Stats. 44 Neharika Sabharwal 44 Processor Legal Footnote 44 cx 44 ITEX undertakes 44 Pankhuri Kapoor 44 Sunita Bothra 44 nepalnews.com mk 44 § § #-# [002] 44 Tote Win Rs 44 Morning Communiqué 44 6 pgs #k 44 Anupreet Kaur 44 Ricky Brigante Posted 44 INA § 44 Kinder Morgan Forms 44 ANNUAL REPORT ON FORM 44 Calgary Alberta T2N 44 Chris McKhann March 44 Jeffry McDowell 44 Ark. Sup 44 Shubha Krishnappa 44 http:/www.ahgp.com 44 MICHIGAN ST 44 ADDRESSES section 44 LAVAL QUEBEC Marketwire 44 pressrelease 44 ERIN JORDAN • 44 Mercado de Valores 44 Proc Am 44 Issuer Amended 44 Item 1A 44 NZPA WGT 44 ASoriano Texas 44 Poonam Wadhwani 44 #D [003] 44 Acorda Therapeutics filings 44 #-# Fax +# [003] 44 eid = 44 Eric Fingerhut · 44 #A# [008] 44 RADVISION Form 44 Kangna Agarwal 44 LANSING BUREAU 44 As Yet Unassigned 44 Crime stoppers anonymously 44 PHILIP MORRIS INTERNATIONAL INC. 44 #/#ID nN# 3 44 Noncritical violations found 44 Default Status Reports 44 Sinivit Project 44 Private Issuer #g# 44 Takeovers Regulations 44 Risks Factors 44 function var = 44 recursos 44 Bioenvision filings 44 GREINER • community@dmreg.com 44 Crowbar Ybor City 44 Launton Spts 44 N1 #-# 44 Supplemental Indenture dated 44 BUREAU Published 44 USC § #a b 44 St Helier Jersey 44 SEC Regulation SX 44 RES# [002] 44 Schedule #C 44 Shelf Registration 44 ISuzuki Seattle 44 POP CULTURE WRITER 44 Shania Sampson published 44 Surveillance du Secteur 44 Special Cautionary Notice 44 Witkin Cal 44 • rmyers@news-press.com • 44 Theravance Quarterly Report 44 A#A [001] 44 Toronto Symbole au 44 #QSB 44 § #-#-#.# 44 Winterbourne Utd 44 Purchase dated 44 By Jeremy Moule 44 Looking Statements Except 44 Qty 44 SIFT Rules 43 Nicky Hayden Ducati #m#.#s 43 CHARLES WEBSTER • 43 website www.corcept.com 43 Looking Statements Safe Harbor 43 Death Notices 43 Quantum periodic filings 43 G# [003] 43 captions Forward Looking 43 james.henderson @ pelhampr.com 43 Definitive Proxy Statement Prospectus 43 No.# [005] 43 #.# Kenyan Shilling 43 Dkt. 43 Items affecting comparability 43 Eur Urol 43 Securitiesand Exchange Commission 43 vol.# 43 d BSHS 43 § #A [001] 43 B.2 43 Article ChemPort 43 c.deb Size/MD5 43 spud #-#-# drlg [003] 43 A.3d 43 High Leverage Instalment 43 AND ON FORM 43 Supplementary Data 43 experiences NCI Grades 43 Declared Effective 43 MOORE • RobertMoore@coloradoan.com 43 Solicitation Statement 43 Subparagraph 43 craig.kelly @ addaxpetroleum.com 43 § #a [002] 43 SUBSIDIARY Consolidated Statements 43 b CUSIP Number 43 Nouveau Marche 43 Section #C [001] 43 http:/www.cenveo.com 43 ¼ l 43 CFR #.# b 43 règlement 43 Neka Sehgal 43 Neil Haesler Postmedia News 43 • adamon@rgj.com • 43 Ownership Structure 43 Content Outline 43 ITA Kawasaki ZX 43 USC § #a [003] 43 PS § § 43 Fax +#- 43 xsl template 43 Setanta Staff 43 Laurent Picard 43 Files Amended Form 43 § #-#-# [002] 43 Paula Schaap Reporter 43 Miss. Ct 43 Cropredy Res 43 uncertificated registered 43 Items Impacting Comparability 43 APPENDIX 3B 43 www.sedar.ca 43 Autorité des marches financiers 43 EMBEDDED WORLD 43 cmt 43 Crit Care Med 43 Quarterly Activities 43 Recapitalisation Proposal 43 Ended QTD Ended 43 See USSG § #D#.# 43 U# [006] 43 Combination Agreement 43 alt Sec 43 SWF FLV 43 theSEC 43 Silicon Laboratories filings 43 Memory Legal Footnote 43 dpa rt 43 Tutties 43 USLW 43 J Neurol Neurosurg Psychiatry 43 By Sindre Lia 43 Katherine Dibling 43 BY TAMMY KRIKORIAN 43 Amending Directive 43 # Paris Cedex 43 Administaff filings 43 LAVAL CANADA Marketwire 43 Cabot Microelectronics filings 43 jsmith@equicomgroup.com 43 TranSwitch indebtedness 43 W6M 43 Kim Predham • 43 = null 43 # Fax +# [003] 43 By NALINEE SEELAL 43 Kumar Sangakkara capt wk 43 Qualstar filings 43 Substantial Shareholding 43 Etats membres